January 21, 2024 | Daily JAM, Videos |
Today’s stock pick of the week is Merck, (MRK). Merck’s “problem” is that one of its biggest revenue streams comes from Keytruda, an oncology drug that will be going off-patent in 2028. In 2023, Merck projected new oncology drugs would bring in an additional $10 billion to replace Keytruda’s revenue. At this year’s JPMorgan healthcare conference, the company’s projection was even higher at $20 billion by the 2030s.
December 14, 2023 | Daily JAM, Jubak Picks, MRNA |
Shares of Moderna (MRNA) closed up 925% today, December 14. A personalized vaccine developed by Merck and Moderna helped prevent the recurrence of severe skin cancer for three years, according to new results released today. Patients with severe melanomas who got the vaccine and Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return than those who got Keytruda alone. The news is especially important for Moderna.
June 23, 2022 | ABBV, Daily JAM, Dividend Income, GOLD, Jubak Picks, PXD, Special Reports |
The advice is sound, very sound. Move part (at least of your portfolio to cash and sit out the worst of this bear market on the sidelines. And since you have that cash in hand, you’ll be ready to snap up bargains when the market has put in a bottom (or near the bottom, or on the way up from the bottom…or something.) But right now that’s easier said than done.
November 15, 2021 | Daily JAM, MRK, PFE, Videos |
I’m starting up my videos on JubakAM.com again–this time using YouTube as a platform. My sixty-ninth YouTube video “Trend of the Week Big Pharma for Safety” went up today.
November 11, 2021 | Daily JAM, Videos |
I’m starting up my videos on JubakAM.com again–this time using YouTube as a platform. My sixty-seventh YouTube video “7 Picks for a Confused Market” went up today.
October 4, 2021 | Daily JAM, Morning Briefing |
The Hong Kong Stock Exchange suspended trading in shares of China Evergrande after the Chinese devel... To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing...
October 3, 2021 | Daily JAM, MRK |
Stocks zoomed on Friday on news that Merck (MRK) had developed and successfully trialed a pill that ... To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing...
September 14, 2020 | Daily JAM, Morning Briefing |
As of noon New York time today the Standard & Poor's 500 was up 1.58% and the Dow Jones Industrials had gained 1.37%. The NASDAQ Composite was higher by 2.01% and the Russell 2000 small cap index had picked up 2.11%. The iShares MSCI Emerging Markets ETF (EEM) had...
November 19, 2019 | Daily JAM, MRK |
Merck (MRK) has announced that it will raise its quarterly dividend by 11% to 61 cents a share in the first quarter of 2020. The dividend will be paid on January 8, 2020 to shareholders of record on December 16, 2019. When I revised my Dividend Portfolio holdings last...
November 12, 2019 | CMI, CMWAY, Daily JAM, DLR, IEF, ITW, KMI, MRK, MSFT, OKE, PAC, PFXF, Special Reports, VZ, WBK |
Just to put all the changes in my Dividend Portfolio in one list after my Special Report 3 Ways to Higher Income in a Low Yield Desert Here are the sells: Bank of America (BAC) as of November 1 ING Group (ING) as of November 1 Tapestry (TPR) as of November 1 Westpac...
November 1, 2019 | Daily JAM, Special Reports |
How dry is the current low yield desert Awfully dry. And likely to get drier. Which raises this question: How can income investors find higher returns? Providing three answers to that is the subject of this special report. Let's start with the dryness of the desert....
October 29, 2019 | Daily JAM, Stock Alerts |
 Shares of Merck (MRK) closed up 3.50% today, October 29, after the company reported better than expected third quarter earnings. On a Non-GAAP basis earnings of $1.51 a share beat the Wall Street consensus by 27 cents a share. Revenue of $12.4 billion fell 6.7% year...